|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 12 September 2007
doi: 10.1242/jcs.011254
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
-catenin signaling through inactivation of G
oDepartment of Pharmacology, Health Sciences Center, State University of New York at Stony Brook, Stony Brook, NY 11794-8651, USA
* Author for correspondence (e-mail: feigin{at}pharm.sunysb.edu)
Accepted 30 July 2007
 |
Summary |
|---|
 Top Summary IntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
-catenin pathway controls numerous cellular processes, including differentiation, cell-fate decisions and dorsal-ventral polarity in the developing embryo. Heterotrimeric G-proteins are essential for Wnt signaling, and regulator of G-protein signaling (RGS) proteins are known to act at the level of G-proteins. The functional role of RGS proteins in the Wnt–-catenin pathway was investigated in mouse F9 embryonic teratocarcinoma cells. RGS protein expression was investigated at the mRNA level, and each RGS protein identified was overexpressed and tested for the ability to regulate the canonical Wnt pathway. Expression of RGS19 specifically was found to attenuate Wnt-responsive gene transcription in a time- and dose-dependent manner, to block cytosolic -catenin accumulation and Dishevelled3 (Dvl3) phosphorylation in response to Wnt3a and to inhibit Wnt-induced formation of primitive endoderm (PE). Overexpression of a constitutively active mutant of G
o rescued the inhibition of Lef-Tcf-sensitive gene transcription caused by RGS19. By contrast, expression of RGS19 did not inhibit activation of Lef-Tcf gene transcription when induced in response to Dvl3 expression. However, knockdown of RGS19 by siRNA suppressed canonical Wnt signaling, suggesting a complex role for RGS19 in regulating the ability of Wnt3a to signal to the level of -catenin and gene transcription.
Key words: RGS proteins, Wnt, -catenin, Heterotrimeric G-proteins, RGS19, Frizzled, Go
|
Introduction |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
-catenin are tightly regulated by a multiprotein complex that includes glycogen synthase kinase 3 (GSK3), axin and APC (product of the adenomatous polyposis coli gene) (Ikeda et al., 1998
; Kishida et al., 1998; Zeng et al., 1997). Within the complex, -catenin is phosphorylated and thereby targeted for degradation by the proteasome (Aberle et al., 1997). Upon binding of Wnt3a to its cognate cell-surface heptihelical receptor Frizzled (Fz1), the degradation complex is inhibited, allowing -catenin to accumulate in the cytosol, translocate to the nucleus and activate target genes such as Myc and CyclinD1, by means of Lef-Tcf-sensitive transcription (Molenaar et al., 1996). The mechanism by which stimulation of Fz leads to the inhibition of the degradation complex for -catenin is not fully understood, although it does involve activation of the phosphoprotein Dishevelled (Dvl) (Yanagawa et al., 1995).
Heterotrimeric G-proteins are essential to the Wnt–-catenin pathway, in organisms ranging from Drosophila to vertebrates (Katanaev et al., 2005; Liu et al., 2001; Liu et al., 2005; Malbon, 2004; Malbon, 2005; Slusarski et al., 1997). Gain- and loss-of-function studies in mouse F9 teratocarcinoma embryonic stem cells (Liu et al., 2001) as well as flies (Katanaev et al., 2005) have demonstrated that Go, for example, is crucial for Wnt-stimulated target gene activation. Heterotrimeric G-proteins are a class of GTP-activated molecular switches comprising a G-subunit in complex with a G-G
dimer (Cabrera-Vera et al., 2003). In the inactive state, GDP-bound G subunits are complexed with G-G, inhibiting activation of downstream signaling molecules. Upon activation of the G-protein by its cognate heptihelical receptor [i.e. a G-protein-coupled receptor (GPCR) such as Fz], GDP is exchanged for GTP by the G subunit, allowing dissociation of the G-G dimer. Both the GTP-bound G-subunits and the `free' G-G dimers are available to activate downstream signaling components (Clapham and Neer, 1993), and both have been shown to function in Wnt signaling (Liu et al., 2001; Slusarski et al., 1997). The period of the activation cycle is determined by the hydrolysis of GTP, which terminates the activation.
Heterotrimeric G-subunits possess a slow, intrinsic GTPase activity that can be accelerated by a class of regulatory proteins termed RGS proteins (Hollinger and Hepler, 2002). Over 30 mammalian RGS proteins have been described, each having its own distinct repertoire of G-subunits that it regulates (Hollinger and Hepler, 2002). RGS proteins have been classified into subfamilies (RZ, R4, R7, R12, RA) based upon sequence conservation within the catalytic RGS domain (Ross and Wilkie, 2000). Members of each subfamily share functional characteristics, including regulation of similar subsets of G-subunits. RGS proteins also display modular domains important for protein interactions, for posttranslational modifications and for proper intracellular localization (Burchett, 2000). Several RGS proteins contain cysteine-string regions necessary for palmitoylation and subsequent binding to the plasma membrane. Other RGS proteins possess PDZ, PTB and DEP domains necessary for formation of protein complexes (Burchett, 2000). RGS proteins have been shown to be essential in many G-protein-mediated physiological processes, including visual (Chen et al., 2000) and dopaminergic signal transduction (Rahman et al., 2003), as well as orienting the mitotic spindle during cell division (Malbon, 2005; Martin-McCaffrey et al., 2004). These proteins can act as scaffolds, organizing receptors, G-proteins and their effectors, enhancing efficiency and specificity of signaling interactions (Abramow-Newerly et al., 2006).
As Wnt signaling is under tight regulatory control that requires heterotrimeric G-proteins, we hypothesized that RGS proteins themselves play a role in modulating the output of Wnt signaling, and specifically our first analysis was of the Wnt–-catenin pathway. We show that RGS19 specifically controls signaling of the Wnt–-catenin pathway. Expression of RGS19 attenuates Dvl phosphorylation, -catenin accumulation, Wnt-responsive gene transcription and blocks Wnt-induced differentiation of mouse F9 teratocarcinoma cells by inactivation of Go. However, knockdown of RGS19 protein expression also suppresses Wnt-induced gene transcription and -catenin accumulation, suggesting a complex role for RGS19 in the regulation of Wnt–-catenin signal transduction.
|
Results |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
). These totipotent stem cells can be induced to differentiate into PE by several morphogens, including retinoic acid (Strickland and Mahdavi, 1978) and Wnt3a (Liu et al., 2001). F9 cells also have been used in studies of Wnt–-catenin signal transduction owing to their expression of key mediators of the pathway, including Go, Gq, GSK3, axin, -catenin and Dvl (Liu et al., 2001). Reverse transcription PCR (RT-PCR) was employed to probe the presence of mRNA encoding RGS proteins in F9 cells. Specific primers were designed for each nucleotide sequence and validated for possible crossreactivity through homology searches on NCBI-BLAST. RNA was isolated from F9 cells and reverse transcribed to synthesize cDNA. Expression of 13 RGS proteins was detected (Fig. 1A,B), including members of each of the five RGS subfamilies: R4 (RGS3, RGS5, RGS16), R12 (RGS10, RGS12, RGS14), RZ (RGS20, RGS17, RGS19), RA (axin, conductin) and R7 (RGS9, RGS11).
|
-catenin signaling was examined. Wnt3a stimulation of Fz1 leads to -catenin accumulation and activation of -catenin-sensitive, Lef-Tcf-dependent transcription (Molenaar et al., 1996). In order to probe the possible role of RGS proteins in Wnt–-catenin–Lef-Tcf signaling, all RGS proteins found in the RT-PCR screen were transiently expressed in embryonic F9 cells [excluding the known Wnt signaling components axin (Zeng et al., 1997) and conductin (Behrens et al., 1998)]. The well-known promoter target of Wnt3a action, Lef-Tcf-sensitive transcription, was measured using a luciferase-based -catenin-responsive promoter system. The reporter, termed M50, contains eight consensus Tcf-binding sites upstream of a minimal promoter driving luciferase expression (Veeman et al., 2003). Expression only of RGS19 attenuated Wnt3a-induced gene transcription by more than 50% (Fig. 2A). Overexpression of other RGS proteins, however, including RGS3, 5, 9, 10, 11, 12, 14, 16, 17 and 20, had no effect on Wnt3a stimulation of Lef-Tcf-sensitive transcriptional activation. Western blot analysis of RGS proteins tagged with hemagglutinin (HA) showed similar levels of expression for most of the constructs tested (Fig. 2B). RGS5, RGS12 and RGS14 also were expressed in the F9 cells, albeit at levels less than those routinely observed for RGS19 and some other RGS proteins. Thus, we can state only that, when expressed at the cellular levels shown, RGS5, RGS12 and RGS14 fail to influence signaling of the Wnt–-catenin canonical pathway. RGS19 expression had no effect on a control reporter plasmid containing eight mutated Tcf-binding sites (data not shown). In addition, RGS19 was a high-value target as the PDZ-domain-containing adaptor known as GAIP-interacting protein C-terminus (GIPC) interacts with both RGS19 (De Vries et al., 1998) and Fz (Tan et al., 2001). Both overexpression and suppression of GIPC inhibits induction of neural crest by Fz3 in Xenopus (Tan et al., 2001). Based upon these observations, RGS19 was selected for a more detailed study of its role in Wnt–-catenin signaling.
|
The results from the RT-PCR analysis of RGS19 mRNA were extended to the level of RGS19 protein expression. Crude cytosolic and cell membrane subcellular fractions were prepared from F9 cells, the proteins separated by SDS-PAGE and subjected to immunoblotting (IB). One band (molecular mass 29 kDa) in the cytosolic fraction and two bands (27 kDa and 29 kDa) in the membrane preparation were detected prominently by an RGS19-specific antibody (Fig. 2C). The doublet of RGS19 associated with the membrane is likely to reflect the known protein phosphorylation of this RGS protein, as evidenced by the reduction in the upper band after treatment with alkaline phosphatase, and as described in previous reports (Fischer et al., 2000).
RGS19 overexpression attenuates Wnt3a-induced Lef-Tcf reporter activation
A time-course for Wnt3a-stimulated gene transcription was performed in F9 cells. Wnt3a stimulated an approximately sixfold increase in gene transcription (as measured by luciferase activity, Fig. 3A). Wnt-stimulated gene transcription displayed a sharp increase at six to eight hours following stimulation by Wnt3a. Maximal Wnt-stimulated activity was observed at 10 hours, declining thereafter. Wnt–-catenin signaling was probed in F9 cells transiently transfected with an expression vector harboring RGS19. Expression of RGS19 attenuated the maximal response of Wnt3a-stimulated gene transcription. Transient expression of RGS19 under these conditions suppressed the Wnt3a-induced response by at least 50%. Basal activity and the kinetics of the reporter gene response, by contrast, were largely unaffected by RGS19 expression.
|
-catenin–Lef-Tcf transcription, we sought to establish a dose-response relationship for increased expression of RGS19 protein and the Wnt-stimulated gene transcription response. Increasing levels of RGS19 expression were found to progressively inhibit Wnt3a-mediated gene transcription (Fig. 3B). In the absence of exogenous RGS19, Wnt3a promoted an approximately sixfold increase in reporter activation. At the lowest level of RGS19 expression tested (0.05 µg DNA/well), a small, but reproducible, decrease in Wnt3a-stimulated transcription also was observed. At higher levels of RGS19 expression (0.2 µg DNA/well), Wnt-stimulated gene transcription was inhibited by 33%. At the highest level of RGS19 expression tested (0.4 µg DNA/well), both Wnt3a-stimulated as well as basal transcriptional activity were found to be markedly suppressed. The expression level of HA-tagged RGS19 agrees well with the relative amount of DNA used in the transfections, as documented by immunoblotting of whole-cell extracts subjected to SDS-PAGE and immunoblotted with an antibody against HA (Fig. 3B). The expression of HA-RGS19 at the highest level tested represents less than 10% of endogenous RGS19 (data not shown).
To address the specificity of the effect of overexpression of RGS19 protein, a homologous member of the RZ subfamily (RGS17) was also expressed to analyze its influence on Wnt3a–-catenin signaling. RGS17 is 58% identical (76% similar) in amino acid sequence to RGS19 and in vitro accelerates the GTPase activity of several G subunits (Mao et al., 2004). Expression of RGS17 was found to have no effect on Wnt3a-induced activation of Lef-Tcf-sensitive transcription (Fig. 3C). Increased expression of RGS19, by contrast, progressively inhibited Wnt3a-mediated gene transcription (Fig. 3B,C). Expression of RGS17 did not alter Lef-Tcf transcription, even at the highest levels of transfection with the same expression vector harboring RGS19. Expression levels of HA-tagged RGS17 and HA-tagged RGS19 were similar, as documented by immunoblotting of whole-cell lysates subjected to SDS-PAGE and detected with an antibody against HA (Fig. 3D). Thus, expression of RGS19 protein attenuates the Wnt3a–-catenin–Lef-Tcf pathway in a specific, dose-dependent and time-dependent manner, whereas expression of the highly homologous RGS17 protein does not.
Constitutively active Go rescues inhibition of Wnt3a action by RGS19
RGS proteins regulate heterotrimeric G-protein signaling by accelerating GTP hydrolysis by the activated G-subunit. If the hypothesis that RGS19 attenuates Wnt3a function by this mechanism is correct, then expression of a mutant G-protein that remains in the active state would be expected to rescue the RGS19 effect. We tested the ability of the expression of constitutively active G subunits to rescue the inhibitory effects of RGS19 on Wnt3a-mediated gene transcription (Fig. 4A). Transient transfection with an expression vector harboring the constitutively active Q205L mutant of Go was able to rescue Wnt3a-stimulated Lef-Tcf activation in cells expressing RGS19 protein (Fig. 4A, left-hand panel). Expression of the constitutively active Q209L mutant of G11, or the constitutively active Q209L mutant of Gq, by contrast, failed to rescue the Wnt3a-stimulated transcription in RGS19-expressing cells (Fig. 4A, right-hand and lower panels). Expression of either G-protein alone had no effect on Wnt3a-stimulated gene transcription. Expression of each G-protein was established by immunoblotting of whole-cell lysates subjected to SDS-PAGE and detected with antibodies specific for each protein (Fig. 4B). Note that the mutant form of Go displays a small, but reproducibly greater, mobility in these gels.
|
RGS19 expression attenuates the -catenin stabilization that results from Wnt3a stimulation
A hallmark of canonical Wnt signaling is the intracellular accumulation of -catenin (Peifer et al., 1994). If our hypothesis that RGS19 expression accelerates deactivation of Go and thereby suppresses Wnt3a-stimulated Lef-Tcf-sensitive transcription is correct, then one would predict that overexpression of RGS19 should counter the stabilizing effect of Wnt3a on intracellular -catenin accumulation (Fig. 5). Basal levels of cytosolic -catenin are low in the absence of stimulation of the canonical pathway by Wnt3a (Fig. 5A). Upon stimulation by Wnt3a, -catenin accumulates in the cytosol, with a peak of intracellular accumulation of -catenin occurring at 2-3 hours. This Wnt3a-stimulated accumulation of -catenin was observed for more than 5 hours (Fig. 5A). We tested our hypothesis by overexpressing RGS19 in F9 cells and then measuring -catenin levels in the cytosol of cells not treated with Wnt3a (time=0). -catenin levels were suppressed in F9 cells overexpressing RGS19 protein (time=0). The intracellular accumulation of -catenin in response to stimulation by Wnt3a was obvious in control cells and clearly countered by overexpression of RGS19 protein. The maximal level of -catenin still occurs at 
3 hours in cells expressing RGS19 protein but remains well below the -catenin levels observed in the cytosol of cells transfected with an empty vector. Quantification of the data from multiple experiments confirms, at the level of -catenin, our hypothesis that RGS19 regulates Wnt3a control of Lef-Tcf transcription (Fig. 5B).
|
-catenin signaling upstream of Dvl-catenin degradation and downstream of activation of Fz1 (Gonzalez-Sancho et al., 2004; Yanagawa et al., 1995). Analysis by SDS-PAGE reveals nonphosphorylated and phosphorylated forms of Dvl3 in F9 cells (Fig. 6A). In the absence of Wnt stimulation (i.e. at 0 minutes), two Dvl3 isoforms (82 kDa, 85 kDa) are apparent, their presence presumed to reflect different degrees of protein phosphorylation. To establish whether these isoforms of Dvl3 are truly differentially phosphorylated forms of the protein, we treated the samples with purified calf intestinal alkaline phosphatase (Fig. 6B). Upon alkaline phosphatase treatment, only the band with highest mobility remained, providing evidence to support the tenet that the band of slower mobility is indeed the phosphorylated form of Dvl3.
|
If the hypothesis that RGS19 exerts its inhibitory effects on Wnt–-catenin signaling at the level of Go is correct, then activation of the pathway at a level downstream of the G-protein should be resistant to RGS19 action. Expression of Dvl3 results in stimulation of Lef-Tcf-sensitive gene transcription (Fig. 6C). Expression of RGS19 is unable to block Dvl3-mediated transcription, bolstering evidence that RGS19 inhibits Wnt action upstream of Dvl phosphorylation.
Overexpression of RGS19 protein attenuates Wnt3a-induced formation of PE
Wnt3a and retinoic acid (RA) both stimulate F9 cells to form PE, an essential step in early stages of mouse development, through distinct signaling pathways. F9 cells promoted to PE no longer express embryonic markers but instead express increased PE-specific markers, including cytokeratin endo A, recognized by the monoclonal antibody TROMA (Strickland and Mahdavi, 1978). These F9 cells form PE in response to Wnt3a or RA, demonstrated by an increase in the expression of the cytokeratin endo A marker (Fig. 7A). Cells transfected with an expression vector harboring RGS19 display a reduction in the PE-specific marker after Wnt3a stimulation (Fig. 7A). By contrast, RGS19 does not block the ability of RA to induce expression of cytokeratin endo A and formation of PE. Quantification of the data from several experiments indicates that overexpression of RGS19 attenuates Wnt3a-induced PE formation by 50% (Fig. 7B), similar in magnitude to its suppression of signaling from Go, to its suppression of the level of -catenin and to the reduced level of induction of Lef-Tcf-sensitive gene transcription.
|
Indirect immunofluorescence was utilized to further characterize the expression of the cytokeratin endo A marker upon Wnt3a treatment (Fig. 7C). Untreated F9 cells do not stain with the TROMA antibody. However, cells treated with Wnt3a showed an increase in fluorescence, indicating expression of cytokeratin endo A and formation of PE. Overexpression of RGS17 had no effect on the ability of Wnt3a to induce formation of PE. However, cells expressing RGS19 were unable to form PE and showed decreased TROMA staining.
Knockdown of RGS19 attenuates Wnt3a-induced Lef-Tcf reporter activation and -catenin accumulation
In order to further define the role of RGS19 in Wnt–-catenin signaling, specific siRNA constructs were utilized to knockdown RGS19 protein expression in F9 cells. Cells treated with a `control' siRNA sequence provided by the commercial supplier displayed a robust Lef-Tcf transcriptional response to Wnt3a stimulation (Fig. 8A). By contrast, cells treated with an siRNA directed against RGS19 showed a >50% decrease in Wnt3a-stimulated gene transcription. Two distinct siRNA sequences directed against RGS19 were tested, each giving similar responses to Wnt3a-mediated gene transcription (data not shown). Western blot analysis confirmed that the specific siRNA directed against RGS19 was effective, reducing RGS19 protein levels to less than 10% of those of control cells (Fig. 8B).
|
-catenin pathway, we examined -catenin stabilization in response to Wnt3a in cells treated with or without the RGS19 siRNA (Fig. 8C). Cells transfected with the control siRNA displayed a marked accumulation of cytosolic -catenin 2 hours after Wnt3a stimulation, and -catenin levels remained stable past 4 hours. Knockdown of RGS19 countered the Wnt3a-mediated accumulation of -catenin by 50%, at both 2-hour and 4-hour time-points while having no effect on basal -catenin levels.
As both overexpression and knockdown of RGS19 attenuated Wnt–-catenin signaling, we hypothesized that perhaps some optimal level of RGS19 was necessary for maximal signaling output. In order to address this issue, a `rescue' experiment was performed by adding increasing amounts of RNAi-resistant RGS19 cDNA to cells lacking endogenous RGS19 (Fig. 8D). As shown above, transfection of F9 cells with siRNA directed against RGS19 attenuated Wnt3a-stimulated gene transcription by 50%. Addition of low levels of exogenous RGS19 (0.2 µg) was able to rescue the siRNA-mediated effect and restore wild-type levels of Wnt3a-induced gene transcription. However, increasing amounts of exogenous RGS19 attenuated gene transcription in a dose-dependent manner, highlighting the crucial importance of the level of RGS19 expression in the regulation of Wnt–-catenin signaling.
|
Discussion |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
-catenin pathway plays a crucial role in development (Moon et al., 2004; Nusse, 2005), and dysregulation of this pathway can provoke diseases such as cancer (Reya and Clevers, 2005). Understanding the mechanisms by which cells respond to and modulate the Wnt downstream signals is therefore a focal point of investigation. Recent research has demonstrated that heterotrimeric G-proteins (including Go) are essential transducers of the Wnt–-catenin–Lef-Tcf pathway, from fly to mouse (Katanaev et al., 2005; Liu et al., 2001; Liu et al., 2005; Malbon, 2004; Malbon, 2005; Slusarski et al., 1997). We investigated whether RGS proteins, which can regulate heterotrimeric G-proteins, might also regulate Wnt signaling. RGS proteins act as GTPase-activating proteins (GAPs) for heterotrimeric G-proteins, increasing the intrinsic rate of GTP hydrolysis and accelerating signal termination (Hollinger and Hepler, 2002). RGS family members have essential roles in many physiological processes, including cardiovascular function (Heximer et al., 2003) and visual signal transduction (Chen et al., 2000). Earlier work in Xenopus provided the first suggestion that RGS proteins impact development (Wu et al., 2000). In this earlier study, injection of RNA encoding mouse RGS2 and RGS4 generated developmental defects similar to those observed following injection of a dominant-negative mutant of XWnt-8 (Wu et al., 2000). Overexpression of RGS proteins RGS2 and RGS4 was also observed to block axis duplication resulting from injection of wild-type XWnt-8 (Wu et al., 2000). However, knockdown studies were not performed, precluding conclusive identification of the specific RGS proteins regulating Wnt signaling in this system. These observations can now be understood more fully following demonstration of an obligate role for G-proteins in Wnt signaling (Malbon, 2005).
The current study tests the hypothesis that RGS19 protein regulates Wnt–-catenin–Lef-Tcf signaling through inactivation of Go. RT-PCR was employed to ascertain the expression of mRNA for RGS proteins, focusing on the RZ subfamily member RGS19, in F9 mouse teratocarcinoma cells. RGS19, expressed in embryonic F9 cells, specifically attenuates Wnt3a-stimulated signaling, including Dvl phosphorylation, -catenin accumulation, gene transcription and formation of PE. As G-proteins are known to be positive regulatory elements, our hypothesis was that RGS proteins, if involved, would counter the effects of Wnt3a on the Wnt–-catenin–Lef-Tcf–PE pathway. We found that RGS19 overexpression, as well as its absence, suppressed the Wnt–-catenin pathway.
Heterotrimeric G-proteins are molecular switches that cycle between active (GTP-bound) and inactive (GDP-bound) states through the action of specific GDP-GTP exchange factors (Cabrera-Vera et al., 2003). Both positive and negative regulatory elements are required for control over G-protein signaling output. Upon ligand binding, GPCRs act as positive regulatory elements by exchanging the inhibitory GDP for GTP on the G-protein -subunit. RGS proteins inhibit G-protein activation by stabilizing the transition state of the G-subunit for GTP hydrolysis, resulting in GDP production (Hollinger and Hepler, 2002). If RGS19 acts as a GAP for Go in the Wnt–-catenin pathway, a rescue experiment can be performed through the use of a constitutively activated, mutant form of a G-protein (which cannot be regulated by its cognate RGS proteins). Indeed, cells transfected with Q205L Go, but not Q209L G11or Q209L Gq, were able to restore wild-type levels of Wnt-responsiveness after RGS19 inhibition.
Phosphorylation of Dvl is required for inhibition of the -catenin degradation complex upon activation of the Wnt–-catenin pathway (Yanagawa et al., 1995). Although the kinase responsible for Wnt-stimulated phosphorylation remains elusive, epistasis experiments place Dvl downstream of the heterotrimeric G-protein Go (Katanaev et al., 2005) and, consequently, Dvl3 phosphorylation in response to Wnt3a. Expression of RGS19 suppressed Wnt3a-induced Dvl phosphorylation. In addition, RGS19 was unable to attenuate Dvl3-induced Lef-Tcf reporter activation, suggesting that RGS19 inhibition of Wnt–-catenin signaling occurs upstream of Dvl.
Intracellular accumulation of -catenin in response to Wnt3a stimulation is a defining feature of canonical Wnt signaling (Peifer et al., 1994). Cytosolic -catenin enters the nucleus, binds to members of the Lef-Tcf family of transcription factors and activates transcription of target genes (Molenaar et al., 1996). To confirm the specificity of the RGS19 inhibition of Lef-Tcf-mediated transcription, -catenin accumulation in response to Wnt3a was measured in cells expressing RGS19. RGS19 expression diminished -catenin accumulation in response to Wnt3a. This result agrees with the overarching hypothesis tested herein that RGS19 regulates Wnt–-catenin signaling upstream of -catenin accumulation. Likewise, expression of RGS19 suppressed Wnt3a-induced PE formation in F9 cells, as measured by expression of the marker cytokeratin endo A.
Wnt–-catenin signaling is mediated through the Lef-Tcf family of transcription factors (Molenaar et al., 1996). Lef-Tcf-sensitive signaling was measured through the use of a luciferase-based reporter construct (Veeman et al., 2003). RGS19, but not other RGS proteins, attenuated gene reporter activation in a dose- and time-dependent manner. In order to probe the specificity of the RGS19-induced inhibition of Wnt3a signaling, a closely related RGS protein, RGS17, was also tested for its ability to alter Wnt3a-mediated gene transcription. Expression of RGS17 had no effect on Wnt3a-induced reporter activity. Therefore, although by in vitro reconstitution studies RGS17 has been shown to accelerate GTPase activity of several G proteins including Go, RGS19 is able (and RGS17 unable) to regulate Go in the context of Wnt3a–Fz1 signaling in vivo. This is not a surprising result, given our knowledge about RGS specificity. Early reports on RGS protein action by in vitro reconstitution revealed promiscuity of RGS proteins for G-protein -subunits. RGS4 and RGS19, for example, were shown to act as GAPs in vitro for virtually all members of the Gi family (Berman et al., 1996). The results from in vivo approaches appear to be more complex (Xie et al., 2005). RGS4 and RGS19 can regulate signaling through G-coupled opioid receptors (Xie et al., 2005). However, each RGS protein has been observed to display a distinct preference for regulating signaling through specific receptors, even when coupled to the same G-protein (Xie et al., 2005). Therefore, RGS protein action is not only a function of the G-protein -subunit but also of the GPCR whose action is being regulated and the cellular context that dictates the proper stoichiometry of signaling elements.
RGS proteins negatively regulate G-protein signaling by acting as GAPs for heterotrimeric G-proteins. Therefore, knockdown of RGS proteins would be expected to result in increased signaling output. However, recent studies in Caenorhabditis elegans (Ferkey et al., 2007) and humans (Nishiguchi et al., 2004) have shown that loss of specific RGS proteins can disrupt distinct G-protein-mediated physiological events. In C. elegans, chemosensation is controlled by G-protein-linked signaling cascades that are regulated by RGS-3 (homologous to mammalian RGS8) (Ferkey et al., 2007). Interestingly, animals lacking RGS-3 were unable to respond to strong sensory stimulation, despite the normal role of RGS-3 being to act as a negative regulator of this function. Similarly, light sensing in vertebrates is mediated by G-proteins and regulated by a specific RGS protein, RGS9 (Chen et al., 2000). Humans lacking functional RGS9 protein display slow photoreceptor deactivation, resulting in difficulty adjusting to rapid changes in light intensity (Nishiguchi et al., 2004). Therefore, despite the role of RGS9 as an inhibitor of G-protein signaling, loss of RGS9 also results in impaired visual signal transduction. In the present study, we show that both the extremes of overexpression and of knockdown of RGS19 protein attenuate Wnt3a–-catenin signaling. Titration of RGS19 protein levels through either siRNA-mediated knockdown or overexpression of RNAi-resistant RGS19, however, highlights the crucial importance of proper levels of RGS19 for maximal Wnt–-catenin signal transduction. In addition, overexpression or knockdown of the RGS19-binding partner GIPC inhibits Wnt signaling in Xenopus, suggesting a common necessity for proper physiological stoichiometry. That RGS proteins function as more than simple negative regulators of G-proteins reflects the need for more detailed probes into the complex roles for RGS19 in Wnt signal transduction.
|
Materials and Methods |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
oA, Q209L G11 and Q209L Gq were obtained from UMR cDNA Resource Center (University of Missouri-Rolla, MO). Expression vectors containing Fz1 and M50 were provided by Randall Moon (Dept of Pharmacology, HHMI, University of Washington, Seattle, WA). Expression vectors encoding RGS11 and RGS12 were provided by David Siderovski (University of North Carolina, Chapel Hill, NC).
Antibodies
The rabbit antibody against RGS19 was provided by Susanne Mumby (Dept of Pharmacology, University of Texas, Southwestern Medical Center, Dallas, TX). The monoclonal TROMA-1 antibody, recognizing the PE marker cytokeratin endo A, was generated by the University of Iowa Developmental Studies Hybridoma Bank (Iowa City, IA). The rabbit antibody against -catenin and the mouse antibody against actin were obtained from Sigma (St Louis, MO). The mouse antibody against Dvl3 (4D3) and the antibodies against Go and G11 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The rat antibody against HA was obtained from Roche (Indianapolis, IN). The antibody recognizing Gq was obtained from BD Biosciences (San Jose, CA).
Cell culture and transfection
Mouse F9 teratocarcinoma cells were obtained from the ATCC (Manassas, VA) and maintained in Dulbecco's modified Eagle's medium supplemented with 15% fetal bovine serum plus penicillin (60 µg/ml) and streptomycin (100 µg/ml) in a humidified atmosphere chamber supplied with 5% CO2 at 37°C. Cells were transfected by using Lipofectamine (Invitrogen, Carlsbad, CA), according to the manufacturer's suggested protocol.
Reverse-transcription polymerase chain reaction
Specific primers for amplification of regions of genes encoding the various RGS proteins and cyclophilin A (CycA) were obtained from Operon (Huntsville, AL) (Table 1). RNA was isolated from wild-type F9 cells using the RNA STAT-60 reagent (Tel-Test, Friendswood, TX) according to the manufacturer's suggested protocol. Briefly, medium was removed from confluent cultures of F9 cells, followed by addition of RNA STAT-60. Cells were pipetted vigorously into microfuge tubes and incubated at room temperature for 5 minutes, then vortexed in the presence of chloroform. After a brief centrifugation, the upper aqueous layer was collected into a fresh tube. Three phenol-chloroform extractions were performed, followed by isopropanol precipitation. The RNA pellet was washed with 75% ethanol and air-dried. Finally, the RNA was dissolved in water treated with diethylpyrocarbonate and stored at –80°C. The reverse-transcription reaction was then performed using the Invitrogen Superscript system. RNA (0.7 µg/µl) was mixed with oligo-dT15 primers and incubated for 3 minutes at 85°C. First-strand buffer, dithiothreitol (DTT) and dNTPs were added and incubated at 42°C for 2 minutes. Finally, Superscript II reverse transcriptase was added and incubated at 42°C for 1 hour. The reaction was stopped by heating the mixture to 85°C for 10 minutes.
|
Primer sets (0.5 µM) were mixed with dNTPs (1 mM), F9 cDNA (100 ng), 10x Pfu buffer and Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA). The PCR reaction was performed using the GeneAmp PCR System 2400 (Applied Biosystems, Foster City, CA) with the following protocol: 95°C, 5 minutes; (95°C, 1 minute; 60°C, 1 minute; 72°C, 3 minutes) 30 cycles; 72°C, 15 minutes. Reaction products were resolved electrophoretically upon 1% agarose gels and then stained and made visible with ethidium bromide.
Membrane preparation
Confluent F9 cells were washed with ice-cold PBS, detached from the culture plate with PBS containing 2 mM EDTA and collected by centrifugation. The cells were resuspended in buffer comprising 20 mM Hepes, pH 7.4, 2 mM MgCl2 and 1 mM EDTA (HME buffer) plus leupeptin (5 µg/ml), aprotinin (5 µg/ml) and phenylmethylsulphonylfluoride (PMSF; 200 nM), and incubated on ice for 15 minutes. Homogenization was performed with a Dounce homogenizer, and nuclei were removed by a low-speed centrifugation (700 g). The post-nuclear supernatant was then centrifuged at 17,000 g and the `crude membrane' pellet resuspended in HME buffer. The Lowry method was used to determine protein concentration.
Gene transcription assay
F9 cells were seeded into 12-well plates and transiently transfected as described above. Following incubation for 48 hours at 37°C, cells were serum starved overnight, then treated with purified Wnt3a (R&D Systems, Minneapolis, MN). Cells were lysed directly on the plates through addition of diluted cell culture lysis reagent 5X (Promega, Madison, WI). Lysates were collected into chilled microfuge tubes on ice and centrifuged at 15,000 g for 5 minutes. The supernatant was transferred into a new tube and directly assayed as described below. A sample (20 µl) of lysate was added to 100 µl of luciferase assay buffer (20 mM Tricine, pH 7.8, 1.07 mM MgCO3, 4 mM MgSO4, 0.1 mM EDTA, 0.27 mM coenzyme A, 0.67 mM luciferin, 33.3 mM DTT, 0.6 µM ATP), and a luminometer (Berthold Lumat LB 9507) was used to measure luciferase activity.
Cytosolic -catenin assay
In order to separate cytosolic from membrane-associated -catenin, samples were treated first with concanavalin A (Con A) (Aghib and McCrea, 1995). Con A (covalently linked to sepharose) was obtained from Amersham Biosciences (Upsala, Sweden). Confluent F9 cells were washed once with PBS and lysed in RIPA buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100) plus leupeptin, aprotinin and PMSF. After collection into microfuge tubes on ice, lysates were rotated at 4°C for 20 minutes and then centrifuged for 25 minutes at 20,000 g. The protein concentration of the supernatant fraction was determined and lysates were diluted with RIPA buffer to a protein content of 2.5 mg/ml. 60 µl of Con-A–sepharose was added to each sample, which then was incubated at 4°C for 1 hour with rotation. After a brief centrifugation, the supernatant was aspirated into a new tube, 30 µl of Con-A–sepharose was added and the samples were rotated for another hour. Finally, the supernatant was removed and the protein concentration determined. The samples were subjected to SDS-PAGE on 10% acrylamide gels, the separated proteins transferred to nitrocellulose blots, and the blots probed with the antibody against -catenin.
Indirect immunofluorescence
F9 cells grown in 24-well plates were fixed in 3% paraformaldehyde, then washed three times in MSM-PIPES buffer (18 mM MgSO4, 5 mM CaCl2, 40 mM KCl, 24 mM NaCl, 5 mM PIPES, 0.5% Triton X-100, 0.5% NP40). Cells were incubated at 37°C for 30 minutes with the TROMA antibody, washed with MSM-PIPES, and then incubated at 37°C for 30 minutes with an anti-mouse antibody coupled to Alexa Fluor 488 (Invitrogen). Cells were then washed in blotting buffer (560 mM NaCl, 10 mM KPO4, 0.1% Triton X-100, 0.02% SDS) and imaged with a Zeiss LSM510 inverted fluorescence microscope.
siRNA vector generation
The pSilencer siRNA expression vector from Ambion (Austin, TX) was used to drive expression of specific siRNAs in F9 cells. A DNA sequence encoding a short hairpin RNA targeted against RGS19 was cloned into the pSilencer vector according to the manufacturer's instructions. Sense and antisense oligonucleotides were generated by Operon (Huntsville, AL). The sequences are as follows: Sense: GATCCGCCCTAAGGAAGTACAGAGTTCAAGAGACTCTGTACTTCCTTAGGGCTTA; Antisense: AGCTTAAGCCCTAAGGAAGTACAGAGTCTCTTGAACTCTGTACTTCCTTAGGGCG. The siRNA vectors were transfected into F9 cells using lipofectamine 2000 (Invitrogen, Carlsbad, CA), according to the manufacturer's suggested protocol. Cell lysates were collected 72 hours after transfection and RGS19 protein levels determined.
|
Acknowledgments |
|---|
|
References |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. (1997). beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804.[CrossRef][Medline]
Abramow-Newerly, M., Roy, A. A., Nunn, C. and Chidiac, P. (2006). RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell. Signal. 18, 579-591.[CrossRef][Medline]
Aghib, D. F. and McCrea, P. D. (1995). The E-cadherin complex contains the src substrate p120. Exp. Cell Res. 218, 359-369.[CrossRef][Medline]
Behrens, J., Jerchow, B. A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D. and Birchmeier, W. (1998). Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280, 596-599.
Berman, D. M., Wilkie, T. M. and Gilman, A. G. (1996). GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86, 445-452.[CrossRef][Medline]
Burchett, S. A. (2000). Regulators of G protein signaling: a bestiary of modular protein binding domains. J. Neurochem. 75, 1335-1351.[CrossRef][Medline]
Cabrera-Vera, T. M., Vanhauwe, J., Thomas, T. O., Medkova, M., Preininger, A., Mazzoni, M. R. and Hamm, H. E. (2003). Insights into G protein structure, function, and regulation. Endocr. Rev. 24, 765-781.
Chen, C. K., Burns, M. E., He, W., Wensel, T. G., Baylor, D. A. and Simon, M. I. (2000). Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature 403, 557-560.[CrossRef][Medline]
Clapham, D. E. and Neer, E. J. (1993). New roles for G-protein beta gamma-dimers in transmembrane signalling. Nature 365, 403-406.[CrossRef][Medline]
De Vries, L., Lou, X., Zhao, G., Zheng, B. and Farquhar, M. G. (1998). GIPC, a PDZ domain containing protein, interacts specifically with the C terminus of RGS-GAIP. Proc. Natl. Acad. Sci. USA 95, 12340-12345.
Ferkey, D. M., Hyde, R., Haspel, G., Dionne, H. M., Hess, H. A., Suzuki, H., Schafer, W. R., Koelle, M. R. and Hart, A. C. (2007). C. elegans G protein regulator RGS-3 controls sensitivity to sensory stimuli. Neuron 53, 39-52.[CrossRef][Medline]
Fischer, T., Elenko, E., Wan, L., Thomas, G. and Farquhar, M. G. (2000). Membrane-associated GAIP is a phosphoprotein and can be phosphorylated by clathrin-coated vesicles. Proc. Natl. Acad. Sci. USA 97, 4040-4045.
Gonzalez-Sancho, J. M., Brennan, K. R., Castelo-Soccio, L. A. and Brown, A. M. (2004). Wnt proteins induce dishevelled phosphorylation via an LRP5/6-independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol. Cell. Biol. 24, 4757-4768.
Heximer, S. P., Knutsen, R. H., Sun, X., Kaltenbronn, K. M., Rhee, M. H., Peng, N., Oliveira-dos-Santos, A., Penninger, J. M., Muslin, A. J., Steinberg, T. H. et al. (2003). Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111, 1259.[CrossRef][Medline]
Hollinger, S. and Hepler, J. R. (2002). Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54, 527-559.
Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. and Kikuchi, A. (1998). Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 17, 1371-1384.[CrossRef][Medline]
Katanaev, V. L., Ponzielli, R., Semeriva, M. and Tomlinson, A. (2005). Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120, 111-122.[CrossRef][Medline]
Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M., Sakamoto, I., Koyama, S. and Kikuchi, A. (1998). Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J. Biol. Chem. 273, 10823-10826.
Lehtonen, E., Laasonen, A. and Tienari, J. (1989). Teratocarcinoma stem cells as a model for differentiation in the mouse embryo. Int. J. Dev. Biol. 33, 105-115.[Medline]
Liu, T., DeCostanzo, A. J., Liu, X., Wang, H., Hallagan, S., Moon, R. T. and Malbon, C. C. (2001). G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science 292, 1718-1722.
Liu, X., Rubin, J. S. and Kimmel, A. R. (2005). Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr. Biol. 15, 1989-1997.[CrossRef][Medline]
Malbon, C. C. (2004). Frizzleds: new members of the superfamily of G-protein-coupled receptors. Front. Biosci. 9, 1048-1058.[Medline]
Malbon, C. C. (2005). G proteins in development. Nat. Rev. Mol. Cell Biol. 6, 689-701.[CrossRef][Medline]
Mao, H., Zhao, Q., Daigle, M., Ghahremani, M. H., Chidiac, P. and Albert, P. R. (2004). RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling. J. Biol. Chem. 279, 26314-26322.
Martin-McCaffrey, L., Willard, F. S., Oliveira-dos-Santos, A. J., Natale, D. R., Snow, B. E., Kimple, R. J., Pajak, A., Watson, A. J., Dagnino, L., Penninger, J. M. et al. (2004). RGS14 is a mitotic spindle protein essential from the first division of the mammalian zygote. Dev. Cell 7, 763-769.[CrossRef][Medline]
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O. and Clevers, H. (1996). XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399.[CrossRef][Medline]
Moon, R. T., Kohn, A. D., De Ferrari, G. V. and Kaykas, A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691-701.[CrossRef][Medline]
Nishiguchi, K. M., Sandberg, M. A., Kooijman, A. C., Martemyanov, K. A., Pott, J. W., Hagstrom, S. A., Arshavsky, V. Y., Berson, E. L. and Dryja, T. P. (2004). Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation. Nature 427, 75-78.[CrossRef][Medline]
Nusse, R. (2005). Wnt signaling in disease and in development. Cell Res. 15, 28-32.[CrossRef][Medline]
Peifer, M., Sweeton, D., Casey, M. and Wieschaus, E. (1994). wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development 120, 369-380.[Abstract]
Rahman, Z., Schwarz, J., Gold, S. J., Zachariou, V., Wein, M. N., Choi, K. H., Kovoor, A., Chen, C. K., DiLeone, R. J., Schwarz, S. C. et al. (2003). RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38, 941-952.[CrossRef][Medline]
Reya, T. and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843-850.[CrossRef][Medline]
Ross, E. M. and Wilkie, T. M. (2000). GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69, 795-827.[CrossRef][Medline]
Slusarski, D. C., Corces, V. G. and Moon, R. T. (1997). Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390, 410-413.[CrossRef][Medline]
Strickland, S. and Mahdavi, V. (1978). The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15, 393-403.[CrossRef][Medline]
Tan, C., Deardorff, M. A., Saint-Jeannet, J. P., Yang, J., Arzoumanian, A. and Klein, P. S. (
